Expects To See Substantial Sales Growth Balance of Year
SAN DIEGO, Aug. 17 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX), will present at the Noble Financial Equity Conference at 11:30 a.m. EDT on Tuesday, August 21, 2007 at the Charleston Place Hotel in Charleston, South Carolina.
William Spencer, Imagenetix's Chief Executive Officer will provide a 25 minute presentation outlining the science, products, and prospects for the Company. Commenting on the prospects, Mr. Spencer said, "I believe that the imminent publication of our most recent clinical study, for our Celadrin product, will lead to significant growth in our private label and branding business. Our distributor is negotiating with several large multinational companies for sale of the private label products, particularly in the International Market. We expect these sales in addition to our growth in retail sales to generate substantial growth in sales during the balance of the year."
The presentation with streaming video and PowerPoint, will be webcast live on Noble Financial's conference website at http://www.two-007.net. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.
Based in San Diego, California, Imagenetix, (OTC Bulletin Board: IAGX)
is an innovator of scientifically tested, natural-based, proprietary
bioceutical products developed to enhance human health on a global basis.
Imagenetix develops, formulates and private-labels propriety
over-the-counter topical creams, skincare products and nutritional
supplements to be marked globally through multiple channels of
distribution. In addition, the company develops patentable compounds for
entering into licensing agreements with pharmaceutical partners. Imagenetix
is the creator of Inflame Away(TM)- Celadrin(R), which has been clinically
|SOURCE Imagenetix, Inc.|
Copyright©2007 PR Newswire.